Official EU label nameGlossary entry 6362
CI 15800
This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.
Global evidence snapshot
The resolved identity has matching regulatory evidence in 6 of 13 indexed market datasets: 6 country records and 1 EU Annex records. Every result and evidence gap is listed below.
Markets checked
13
Markets with evidence
6
Evidence gaps
7
Resolved identifiers
4
A missing local match is not permission, approval or proof of safety. It means no strong identity match was resolved in that indexed dataset.
Resolved substance identity
CAS:6371-76-227757-79-5
EC:228-899-7248-638-0
Ingredient index records:
CI 15800
Cosmetic functions: COLORANT
Calcium bis[3-hydroxy-4-(phenylazo)-2-naphthoate]
Inventory restriction note: IV/26 (CI 15800) II/1331 (Pigment Red 64:1; CI 15800: when used as a substance in hair dye products)
8 matched or reported names
CI 15800Calcium bis[3-hydroxy-4-(phenylazo)-2-naphthoate]Calcium bis[3-hydroxy-4-(phenylazo)-2-naphthoate] (Brilliant Lake Red R)3-Hydroxy-4-(phenylazo)-2-naphthoic acid and its calcium salt (Pigment Red 64:1; CI 15800), when used as a substance in hair dye products3-Hydroxy-4-(phenylazo)-2-naphthoic acid and its calcium saltÁcido 3-hidroxi-4-(fenilazo)-2-naftóico e seu sal de cálcio (Pigmento Vermelho 64:1; CI 15800), quando usado como substância que entra na composição de corantes capilares3-Hydroxy-4-(phenylazo)-2-naphthoic acid (CAS No. 27757-79-5) and its calcium salt (pigment red 64:1; CI 15800) (CAS No. 6371-76-2), when used as a substance in hair dye products3-Hydroxy-4-(phenylazo)-2-naphthoic acid and its calcium salt (Pigment Red 64:1; CI 15800) when used as a substance in hair dye products
Regulatory evidence in all 13 markets
Open each matched record for its scope, concentration, conditions, warnings and official source version.
Swipe or scroll horizontally to see dataset coverage and next actions.
| Market | Result | Records | Dataset | Meaning / next action |
|---|---|---|---|---|
| European Union EU | Conditional positive-list match | 1Open record 1 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | Review every linked record and exact conditions. |
| Great Britain GB | No local match | 0 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework. |
| Canada CA | No local match | 0 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | The Hotlist is an administrative compliance tool, not an exhaustive safety approval list. |
| New Zealand NZ | Prohibited | 2Open record 1Open record 2 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | Review every linked record and exact conditions. |
| ASEAN ASEAN | Prohibited | 1Open record 1 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | Review every linked record and exact conditions. |
| China CN | No local match | 0 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately. |
| Japan JP | No local match | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | No local match | 0 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | Korean source wording is canonical and other positive lists/notices may still apply to the formulation. |
| United States US | No local match | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | No local match | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | Prohibited | 1Open record 1 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | Review every linked record and exact conditions. |
| India IN | Prohibited | 1Open record 1 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | Review every linked record and exact conditions. |
| Saudi Arabia SA | Prohibited | 1Open record 1 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | Review every linked record and exact conditions. |
No market rows match this filter.
Matching market records and conditions
New Zealand
Cosmetic Products Group Standard schedules effective 1 January 2026Calcium bis[3-hydroxy-4-(phenylazo)-2-naphthoate] (Brilliant Lake Red R)Permitted list with conditions
Colour index: 15800 · CAS: 6371-76-2 · Colour: Red · Product scope: Not to be used in products applied on mucous membranes
Schedule 6, reference 26, source row 27 · effective-2026-01-01
3-Hydroxy-4-(phenylazo)-2-naphthoic acid and its calcium salt (Pigment Red 64:1; CI 15800), when used as a substance in hair dye productsProhibited
Schedule 4, reference 1331, source row 1401 · effective-2026-01-01
ASEAN
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026Brazil
ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026India
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)Saudi Arabia
SFDA live prohibited/restricted lists, snapshot 30 August 2026Exact Annex II–VI evidence
Annex IVentry 26
Open full regulatory recordCI 15800
Maximum concentration: Not to be used in products applied on mucous membranes
Chemical identity and properties
CAS 27757-79-5PubChem CID 80753
3-Hydroxy-4-(phenylazo)-2-naphthoic acid
- IUPAC name
- 3-hydroxy-4-phenyldiazenylnaphthalene-2-carboxylic acid
- Molecular formula
- C17H12N2O3
- Molecular weight
- 292.29 g/mol
- Exact mass
- 292.08479225 Da
- XLogP3
- 4.7
- Topological polar surface area
- 82.3 Ų
- Hydrogen-bond donors
- 2
- Hydrogen-bond acceptors
- 5
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
2-Naphthalenecarboxylic acid, 3-hydroxy-4-(phenylazo)-EINECS 248-638-0NSC 11713DYMRMULFWJUGDJ-UHFFFAOYSA-N2-Naphthalenecarboxylicacid, 3-hydroxy-4-(2-phenyldiazenyl)-NSC-117133-Hydroxy-4-phenylazo-2-naphthoic acid4-phenylazo-3-hydroxy-2-naphthoic acid
3 more reported names
NCI60_000394DS-0011603-Hydroxy-4-(phenyldiazenyl)naphthalene-2-carboxylic acid
External database identifiers
- ChEMBL:CHEMBL1976469
- EPA DTXSID:DTXSID8091538
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 6371-76-2PubChem CID 135565537
D & C Red no. 31
- IUPAC name
- calcium bis(3-carboxy-1-phenyldiazenylnaphthalen-2-olate)
- Molecular formula
- C34H22CaN4O6
- Molecular weight
- 622.6 g/mol
- Exact mass
- 622.1165253 Da
- Topological polar surface area
- 170.0 Ų
- Hydrogen-bond donors
- 2
- Hydrogen-bond acceptors
- 10
- Covalent units
- 3
- Defined stereocentres
- 0
Also known as
D&C Red No. 31Brilliant Lake MBrilliant lakered RTopaz Toner R 5Brilliant Scarlet GJapan Red 219Brilliant Red Toner RA11067 Red
16 more reported names
D and C Red No. 31Red No. 219CI 15800Red 219Symuler Brilliant Scarlet GDainichi Brilliant Scarlet GDainichi Brilliant Scarlet RGCCRIS 4906C.I. 15800 Ca SaltEINECS 228-899-7O63T5PV73PCI 15800:1 (Ca salt)R 2192-Naphthalenecarboxylic acid, 3-hydroxy-4-(phenylazo)-, calcium salt (2:1)AKA219RED 31
External database identifiers
- EPA DTXSID:DTXSID7064283
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Additional authoritative substance research
These source-specific lookups can add hazard, toxicology, identity and assessment context. A link is a research route, not a claim that the source contains an exact record.
Cosmetic Ingredient Review safety assessments
Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents
Independent expert review considered by FDA; not a government approval or binding market rule
Research this identityFDA Global Substance Registration System
UNII identifiers, preferred names, substance types, codes and public substance relationships
Identity registry only; UNII availability does not imply FDA review or approval
Research this identityILO/WHO International Chemical Safety Cards
Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals
International occupational chemical-safety reference; not cosmetic-use approval
Research this identityJapan NITE-CHRIP
Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information
Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules
Research this identityNIOSH Pocket Guide to Chemical Hazards
REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals
US occupational-health guidance and limits; not a cosmetic ingredient decision
Research this identityOECD eChemPortal
Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records
Discovery gateway; each linked authority remains responsible for its data
Research this identityUS EPA CompTox CTX APIs
DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data
Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality
Research this identityContinue the compliance check
1. Confirm identity
Match the supplier specification, CAS/EC identifiers and composition to this official label name. Similar wording is not proof of chemical equivalence.
2. Review restrictions
Check every exact Annex record shown above, plus CMR, nanomaterial, SCCS and later-amendment requirements that may apply.
3. Verify the formula
Evaluate concentration, product type, purity, warnings, claims and each target market before making a compliance decision.
Official source and scope
Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.
Open official Decision